Promising Outlook for Lexicon Pharmaceuticals’ LX9211 as a Novel Treatment for Diabetic Peripheral Neuropathic Pain
Leerink Partners analyst Roanna Ruiz has maintained their bullish stance on LXRX stock, giving a Buy rating yesterday.Invest with Confidence: ...
The 5 common sleep habits that ‘increase your risk of silent killer’ – and 3 signs you already have it
SLEEP is essential for good health and well-being. It keeps heart health in check, helps you maintain a healthy weight, makes ...